Respiratory syncytial virus prevention in children with congenital heart disease: who and how?
Respiratory syncytial virus (RSV) is a major cause of respiratory infection in children. Most of the pediatric population have RSV infection before the age of 2, and recurrent infections are common even within one season. Chronic lung disease, prematurity, along with congenital heart disease (CHD) a...
Main Authors: | Nam Kyun Kim, Jae Young Choi |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Pediatric Society
2011-05-01
|
Series: | Korean Journal of Pediatrics |
Subjects: | |
Online Access: | http://kjp.or.kr/upload/pdf/kjped-54-197.pdf |
Similar Items
-
Respiratory syncytial virus infection in children with congenital heart disease: global data and interim results of Korean RSV-CHD survey
by: Jo Won Jung
Published: (2011-05-01) -
Cost-utility analysis of palivizumab for preventing respiratory syncytial virus in preterm neonates and infants in Colombia
by: Jaime E. Ordóñez, et al.
Published: (2024-04-01) -
Resurgence of Respiratory Syncytial Virus in Children: An Out-of-Season Epidemic in Portugal
by: Ana Rita Torres, et al.
Published: (2023-01-01) -
Palivizumab in the prevention of severe respiratory syncytial virus infection in children with congenital heart disease; a novel cost-utility modeling study reflecting evidence-based clinical pathways in Spain
by: Ralph Schmidt, et al.
Published: (2017-12-01) -
Respiratory Syncytial Virus infection: New prevention strategies
by: Anna Chiara Vittucci, et al.
Published: (2024-03-01)